Working closely with BioInnovate teammate David Townley, Brian cofounded and is CEO of Neurent Medical, a company developing a novel office-based treatment for Rhinitis, a condition affecting millions of people globally. The duo continued to de-risk the project during a 2-year period, utilising the Enterprise Ireland Commercialisation Fund mechanism and recently closed a Series A round of investment of €9.3 million to progress the project towards CE mark and FDA approval, and commercialisation.